Anna-Maria Hartner, Xiang Li, Susy Echeverria-Londono, Jeremy Roth, Kaja Abbas, Megan Auzenbergs, Margaret J de Villiers, Matthew J Ferrari, Keith Fraser, Han Fu, Timothy Hallett, Wes Hinsley, Mark Jit, Andromachi Karachaliou, Sean M Moore, Shevanthi Nayagam, Timos Papadopoulos, T Alex Perkins, Allison Portnoy, Quan Tran Minh, Emilia Vynnycky, Amy K Winter, Holly Burrows, Cynthia Chen, Hannah E Clapham, Aniruddha Deshpande, Sarah Hauryski, John Huber, Kevin Jean, Chaelin Kim, Jong-Hoon Kim, Jemima Koh, Benjamin A Lopman, Virginia E Pitzer, Yvonne Tam, Philipp Lambach, So Yoon Sim, Kim Woodruff, Neil M Ferguson, Caroline L Trotter, Katy A M Gaythorpe
BACKGROUND: There have been declines in global immunisation coverage due to the COVID-19 pandemic. Recovery has begun but is geographically variable. This disruption has led to under-immunised cohorts and interrupted progress in reducing vaccine-preventable disease burden. There have, so far, been few studies of the effects of coverage disruption on vaccine effects. We aimed to quantify the effects of vaccine-coverage disruption on routine and campaign immunisation services, identify cohorts and regions that could particularly benefit from catch-up activities, and establish if losses in effect could be recovered...
April 2024: Lancet Global Health